{
    "2021-04-22": [
        [
            {
                "time": "",
                "original_text": "复锐医疗科技(01696)拟3.12亿元收购复星牙科的全部已发行股本",
                "features": {
                    "keywords": [
                        "复锐医疗科技",
                        "复星牙科",
                        "收购",
                        "3.12亿元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "牙科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药：子公司复宏汉霖自主研发的药物获国家药监局注册申请受理",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复宏汉霖",
                        "药物",
                        "注册申请受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药(02196.HK)：控股子公司获药品注册申请受理",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股子公司",
                        "药品",
                        "注册申请受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药：子公司斯鲁利单抗注射液注册申请获受理",
                "features": {
                    "keywords": [
                        "复星医药",
                        "斯鲁利单抗注射液",
                        "注册申请受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196.SH)：斯鲁利单抗注射液上市注册申请获国家药监局受理并拟纳入优先审评",
                "features": {
                    "keywords": [
                        "复星医药",
                        "斯鲁利单抗注射液",
                        "上市注册申请",
                        "优先审评"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药：旗下自主研发的斯鲁利单抗注射液获药品注册申请受理，并拟优先审评",
                "features": {
                    "keywords": [
                        "复星医药",
                        "斯鲁利单抗注射液",
                        "注册申请受理",
                        "优先审评"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "疫苗板块午后持续走高，康希诺大涨8%",
                "features": {
                    "keywords": [
                        "疫苗板块",
                        "康希诺",
                        "大涨",
                        "8%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}